The Challenges of the Journey from Clinical to Commercial Cell Therapies

Humberto Vega, PhD, Executive Director, Bristol Myers Squibb, discusses the journey from clinical to commercial cell therapies as a part of his session, “Successfully Navigating Global Cell Therapy Requirements.”